Results 51 to 60 of about 4,252 (213)
Titer of input and output phage populations throughout six rounds of biopanning.
, 2021 Titer of input and output phage populations throughout six rounds of biopanning.
Natsinee Anudit (11607867) +4 more
core +1 more source
Strategies to Screen Anti-AQP4 Antibodies from Yeast Surface Display Libraries
Antibodies, 2022 A rapid and effective method to identify disease-specific antibodies from clinical patients is important for understanding autoimmune diseases and for the development of effective disease therapies.
Aric Huang +11 more
doaj +1 more source
Novel Biopanning Strategy To Identify Epitopes Associated with Vaccine Protection [PDF]
Journal of Virology, 2013 ABSTRACTIdentifying immune correlates of protection is important to develop vaccines against infectious diseases. We designed a novel, universally applicable strategy to profile the antibody (Ab) repertoire of protected vaccine recipients, using recombinant phages encoding random peptide libraries.
Barbara C, Bachler +6 more
openaire +2 more sources
BioTechniques, 2015 Amplification bias is a major hurdle in phage display protocols because it imparts additional, unintended selection pressure beyond binding to the desired target.
Benjamin J. Umlauf +2 more
doaj +1 more source
Summary of biopanning outcomes.
, 2013 Summary of biopanning outcomes.
Christopher T. Elliott (407641) +5 more
core +1 more source
Biomolecules, 2021 The discovery of new insecticides improves integrated pest management (IPM), but is usually a long high-risk process with a low probability of success.
Man-Yeon Choi, Robert K. Vander Meer
doaj +1 more source
Efficacy of biopanning for HEV ORF3 mAbs.
, 2015 Efficacy of biopanning for HEV ORF3 mAbs.
Rongchang Liu (770353) +6 more
core +1 more source
Enrichment of phage (% yield) by biopanning.
, 2016 Enrichment of phage (% yield) by biopanning.
Anton Pernthaner (1447363) +5 more
core +1 more source
Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy
Viruses, 2023 The search for innovative anti-cancer drugs remains a challenge. Over the past three decades, antibodies have emerged as an essential asset in successful cancer therapy.
Renato Kaylan Alves França +7 more
doaj +1 more source
VIEW, EarlyView.Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley +1 more source